JP Morgan Private Wealth Advisors’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,475	Closed	-$201K	–	1754
2020 Q3	$201K	Buy	+1,475	New	+$157K	﹤0.01%	1523
2020 Q2	–	Sell	-4,892	Closed	-$229K	–	1616
2020 Q1	$229K	Sell	4,892 -734	-13%	-$47K	﹤0.01%	1242
2019 Q4	$410K	Hold	5,626	–	–	﹤0.01%	1119
2019 Q3	$293K	Hold	5,626	–	–	﹤0.01%	1205
2019 Q2	$282K	Sell	5,626 -4,913	-47%	-$239K	﹤0.01%	1175
2019 Q1	$548K	Buy	10,539 +5,141	+95%	+$237K	﹤0.01%	994
2018 Q4	$264K	Hold	5,398	–	–	﹤0.01%	1234
2018 Q3	$352K	Buy	+5,398	New	+$317K	﹤0.01%	1219

JP Morgan Private Wealth Advisors's MYOK Position: Q4 2020 in Review

JP Morgan Private Wealth Advisors sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 1,475 shares — an estimated $201K sold.

JP Morgan Private Wealth Advisors first reported a position in MYOK in Q3 2018 and held it in 8 quarters. The position peaked at $548K in Q1 2019. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

JP Morgan Private Wealth Advisors reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
JP Morgan Private Wealth Advisors sold 1,475 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $201K.
JP Morgan Private Wealth Advisors first reported a position in MyoKardia, Inc. Common Stock in Q3 2018 and held it in 8 quarters.
JP Morgan Private Wealth Advisors's MyoKardia, Inc. Common Stock position peaked at $548K in Q1 2019.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.